DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Chronic condition involving insulin resistance and elevated blood glucose.
Quick decision tree — answer 2–4 questions, get a personalized recommendation. No email required.

Obesity-medicine telehealth that takes insurance

Tirzepatide for type 2 diabetes

Semaglutide approved for type 2 diabetes

Oral semaglutide for type 2 diabetes (FDA-approved 2019)

Primary care telehealth with GLP-1 prescribing
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Form Health | Brand-name GLP-1 (Wegovy, Zepbound, etc.) | Best ·$99/mo | approved | Top ·8.9 | See offer → |
| 2 | Mounjaro | Tirzepatide | $1349/mo | off-label | 8.7 | See offer → |
| 3 | Ozempic | Semaglutide | $997/mo | off-label | 8.5 | See offer → |
| 4 | Rybelsus | Semaglutide (oral, 14mg max for T2D) | $997/mo | approved | 8.0 | See offer → |
| 5 | PlushCare Weight Loss | Brand-name GLP-1 | Best ·$99/mo | approved | 7.6 | See offer → |
A short read of who wins for which kind of patient.
Recommendation labels are computed from each product’s editorial badges + scoring rubric. See methodology for the full rubric — page /best-glp1-for/type-2-diabetes.